Tokyo, Japan

Yoshihide Miyake

This inventor holds 1 USPTO granted patent. Top assignee: Numab Therapeutics Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihide Miyake. Retrieved from https://idiyas.com/inventor/yoshihide-miyake

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yoshihide Miyake

Introduction

Yoshihide Miyake is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. His work focuses on addressing critical health challenges through advanced scientific research.

Latest Patents

Yoshihide Miyake holds a patent for "Multispecific Antibodies Having Specificity for IL-4R and IL-31, Encoding Nucleic Acids Thereof and Methods of Treating." This patent represents a significant advancement in the treatment of conditions related to interleukin receptors, showcasing his expertise in antibody technology. He has 1 patent to his name.

Career Highlights

Miyake is currently associated with Numab Therapeutics AG, a company known for its innovative approaches in the field of therapeutic antibodies. His role at Numab Therapeutics AG allows him to collaborate with leading scientists and contribute to groundbreaking research.

Collaborations

Yoshihide has worked alongside talented colleagues, including Maria Johansson and Yoshio Arakawa. Their combined efforts in research and development have led to significant advancements in their respective fields.

Conclusion

Yoshihide Miyake's contributions to biotechnology and his innovative patent work highlight his importance in the scientific community. His ongoing research continues to pave the way for new therapeutic solutions that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…